Some topics: The latest financial indicators and existing private and public players in the healthcare sector in India; the impact on U.S. based pharmaceutical companies of India’s upcoming compliance with the WTO product patent regime in the area of pharmaceuticals; potential investment opportunities for U.S. multinational companies including in healthcare infrastructure development, drug manufacturing and licensing and clinical research outsourcing
Ms. Maniar is Chair, and Ms. Alvarez is Co-Chair of this event
This event is CLE approved